- Certificate
- IP-COA-IT-261006
- Issued
- 5 October 2026
- Status
- released
Ipamorelin + Tesamorelin
Lyophilised blend of two growth hormone secretagogues
- 8 mg
- Endotoxin< 0.1 EU/mgKinetic chromogenic LAL
- SterilityNo growthMembrane filtration
- Analysed4 October 2026Batch made 2 October 2026
Full analytical results
Tests and specifications
| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Appearance | Visual inspection | White to off-white lyophilised powder | Conforms | Pass |
| Purity | RP-HPLC, each component separately; the figure shown is the limiting component | ≥ 99.0% for every component | 99.23% | Pass |
| Blend ratio | RP-HPLC, each component quantified against its own reference standard | Each component within ± 5.0% of its declared share | 49.5% / 50.5% | Pass |
| Related substances | RP-HPLC, any single impurity | ≤ 1.0% | 0.41% | Pass |
| Water content | Karl Fischer titration | ≤ 8.0% | 3.68% | Pass |
| pH, 1% aqueous solution | Potentiometry at 25 °C | 4.0 to 7.5 | 5.7 | Pass |
| Bacterial endotoxins | Kinetic chromogenic LAL | < 1.0 EU/mg | < 0.1 EU/mg | Pass |
| Sterility | Membrane filtration (USP <71>) | No growth | No growth | Pass |
| Residual solvents | Headspace GC-FID (USP <467>) | Acetonitrile ≤ 410 ppm, methanol ≤ 3000 ppm, dichloromethane ≤ 600 ppm (ICH Q3C) | Conforms | Pass |
| Elemental impurities | ICP-MS (USP <232> and <233>) | Pb ≤ 5, Cd ≤ 2, As ≤ 15, Hg ≤ 3 µg/day (ICH Q3D, parenteral) | Conforms | Pass |
Components
A blend is only as pure as its weakest component, so the purity at the top of this certificate is the lowest of the figures below, never an average.
| Component | Declared share | Purity | Ion | Observed m/z |
|---|---|---|---|---|
| Ipamorelin | 50.0% | 99.75% | [M+H]+ | 712.78 |
| Tesamorelin | 50.0% | 99.23% | [M+5H]5+ | 1028.01 |
Chromatogram
Reversed-phase trace for this batch. One dominant peak at 17.1 minutes, 99.23% of the total peak area, largest single impurity 0.41%.
Storage and handling
- Unopened
- 2 to 8 °C, away from light
- Long term
- −20 °C, lyophilised, for the stated shelf life
- Reconstituted
- 2 to 8 °C, use within 4 weeks; avoid repeated freeze and thaw
- In transit
- Stable at ambient temperature for up to 30 days
- Reconstitute with
- Bacteriostatic water
The vial this covers
The label on your vial carries the same batch code as this certificate, IP-IT-261002, and the QR goes to the results for it. If the code on the vial is not this one, the certificate for it is on this page under earlier batches.
Sticker shown at its printed size, 40 by 20 mm. Cap colour may vary by batch.
Release
- Batch date
- 2 October 2026
- Analysis date
- 4 October 2026
- Issue date
- 5 October 2026
- Best before
- October 2028
- Released by
- Quality review, Indigo Peptides
- Document
- Valid only in its original, unmodified form
Results are taken from the batch testing documentation for this exact batch, supplied with the finished vials and held on file by us. Every value above is for the batch named on this certificate and for no other.
Holding an older vial?
| Batch | purity | Analysed |
|---|---|---|
| IP-IT-260911 | 99.54% | 13 September 2026 |
If the code on your vial is one of these, it is an earlier batch of ours and these are its results. A result we have published is never removed and never recalculated.
Take it with you
Download this certificate (PDF)
The PDF is this page on A4. Open the printable version to print it yourself.